← Back to headlines





KMI partners with Guardant Health on liquid biopsy cancer screening
The Korea Medical Institute said Tuesday it has signed a memorandum of understanding with US-based Guardant Health to collaborate on liquid biopsy-based precision cancer screening.
12 Mar, 05:09 — 12 Mar, 05:09
Related Stories

Supreme Court’s Euthanasia judgment shows dignity cannot be measured solely in heartbeats
8m ago

Ανατριχίλα από τις αποκαλύψεις για την υπόθεση της 57χρονης καθηγήτριας Αγγλικών: Έρευνα εις βάθος για τις συνθήκες υπό τις οποίες εργαζόταν
11m ago

This is the most powerful treatment for joint pain and osteoarthritis
14m ago

'The patient will finally be able to see his electronic file after 36 years, in an apotheotic ending', announces the Minister of Health
17m ago